Release Date: 14/02/14 17:27 Summary: Half Year Accounts to 31 Dec 2013 Price Sensitive: No Download Document 608.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%